India on Wednesday launched its first indigenously manufactured anti-malaria new-age drug Synriam. The drug, produced by Ranbaxy Laboratories, was formally introduced for marketing here.

The drug, launched by Health Minister Ghulam Nabi Azad in the presence of Science and Technology Minister Vilasrao Deshmukh, has been developed by the company in collaboration with the Department of Science and Technology and supported by the Indian Council for Medical Research.